English
简体中文
Total: £ 56.28
Published Date: 2025-04-24 | Pages: 80 | Tables: 80 | Medical Care
The global Hemophilia Gene Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.
Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.
The global Hemophilia Gene Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics
By Type: (Dominant Segment vs High-Margin Innovation)
Hemophilia A
Hemophilia B
By Application: (Core Demand Driver vs Emerging Opportunity)
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Spark Therapeutics in Europe)
- Emerging Product Trends: Hemophilia A adoption vs. Hemophilia B premiumization
- Demand-Side Dynamics: Hemophilia A Gene Therapy growth in China vs. Hemophilia B Gene Therapy potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Hemophilia Gene Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Hemophilia B in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hemophilia B Gene Therapy in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hemophilia Gene Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Hemophilia A
1.2.3 Hemophilia B
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hemophilia A Gene Therapy
1.3.3 Hemophilia B Gene Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia Gene Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Hemophilia Gene Therapy Revenue Market Share by Region (2020-2025)
2.4 Global Hemophilia Gene Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Hemophilia Gene Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe Hemophilia Gene Therapy Market Size and Prospective (2020-2031)
2.5.3 China Hemophilia Gene Therapy Market Size and Prospective (2020-2031)
2.5.4 Japan Hemophilia Gene Therapy Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Hemophilia Gene Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2020-2025)
3.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types Hemophilia Gene Therapy Representative Players
4 Breakdown Data by Application
4.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2020-2025)
4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Hemophilia Gene Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2020-2025)
5.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue
5.4 Global Hemophilia Gene Therapy Market Concentration Analysis
5.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2024
5.5 Global Key Players of Hemophilia Gene Therapy Head office and Area Served
5.6 Global Key Players of Hemophilia Gene Therapy, Product and Application
5.7 Global Key Players of Hemophilia Gene Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Hemophilia Gene Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.1.2.2 North America Hemophilia Gene Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.1.3.2 North America Hemophilia Gene Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Hemophilia Gene Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe Hemophilia Gene Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe Hemophilia Gene Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Hemophilia Gene Therapy Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.3.2.2 China Hemophilia Gene Therapy Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.3.3.2 China Hemophilia Gene Therapy Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Hemophilia Gene Therapy Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.4.2.2 Japan Hemophilia Gene Therapy Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.4.3.2 Japan Hemophilia Gene Therapy Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Hemophilia Gene Therapy Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Hemophilia Gene Therapy Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Hemophilia Gene Therapy Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
7 Key Players Profiles
7.1 Spark Therapeutics
7.1.1 Spark Therapeutics Company Details
7.1.2 Spark Therapeutics Business Overview
7.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction
7.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.1.5 Spark Therapeutics Recent Development
7.2 Ultragenyx
7.2.1 Ultragenyx Company Details
7.2.2 Ultragenyx Business Overview
7.2.3 Ultragenyx Hemophilia Gene Therapy Introduction
7.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.2.5 Ultragenyx Recent Development
7.3 Shire PLC
7.3.1 Shire PLC Company Details
7.3.2 Shire PLC Business Overview
7.3.3 Shire PLC Hemophilia Gene Therapy Introduction
7.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.3.5 Shire PLC Recent Development
7.4 Sangamo Therapeutics
7.4.1 Sangamo Therapeutics Company Details
7.4.2 Sangamo Therapeutics Business Overview
7.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction
7.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.4.5 Sangamo Therapeutics Recent Development
7.5 Bioverativ
7.5.1 Bioverativ Company Details
7.5.2 Bioverativ Business Overview
7.5.3 Bioverativ Hemophilia Gene Therapy Introduction
7.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.5.5 Bioverativ Recent Development
7.6 BioMarin
7.6.1 BioMarin Company Details
7.6.2 BioMarin Business Overview
7.6.3 BioMarin Hemophilia Gene Therapy Introduction
7.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.6.5 BioMarin Recent Development
7.7 uniQure
7.7.1 uniQure Company Details
7.7.2 uniQure Business Overview
7.7.3 uniQure Hemophilia Gene Therapy Introduction
7.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.7.5 uniQure Recent Development
7.8 Freeline Therapeutics
7.8.1 Freeline Therapeutics Company Details
7.8.2 Freeline Therapeutics Business Overview
7.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction
7.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025)
7.8.5 Freeline Therapeutics Recent Development
8 Hemophilia Gene Therapy Market Dynamics
8.1 Hemophilia Gene Therapy Industry Trends
8.2 Hemophilia Gene Therapy Market Drivers
8.3 Hemophilia Gene Therapy Market Challenges
8.4 Hemophilia Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Hemophilia Gene Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Hemophilia Gene Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Hemophilia Gene Therapy Revenue Share by Region (2020-2025)
Table 6. Global Hemophilia Gene Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Hemophilia Gene Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Hemophilia Gene Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Hemophilia Gene Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Hemophilia Gene Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Hemophilia Gene Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Hemophilia Gene Therapy Application
Table 18. Global Hemophilia Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Hemophilia Gene Therapy Market Share by Players (2020-2025)
Table 20. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2024)
Table 21. Ranking of Global Top Hemophilia Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Hemophilia Gene Therapy, Headquarters and Area Served
Table 24. Global Key Players of Hemophilia Gene Therapy, Product and Application
Table 25. Global Key Players of Hemophilia Gene Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Hemophilia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Hemophilia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Hemophilia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Hemophilia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Hemophilia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Hemophilia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 37. China Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Hemophilia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Hemophilia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 41. Japan Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Hemophilia Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Hemophilia Gene Therapy Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Hemophilia Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Hemophilia Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 47. Spark Therapeutics Company Details
Table 48. Spark Therapeutics Business Overview
Table 49. Spark Therapeutics Hemophilia Gene Therapy Product
Table 50. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 51. Spark Therapeutics Recent Development
Table 52. Ultragenyx Company Details
Table 53. Ultragenyx Business Overview
Table 54. Ultragenyx Hemophilia Gene Therapy Product
Table 55. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 56. Ultragenyx Recent Development
Table 57. Shire PLC Company Details
Table 58. Shire PLC Business Overview
Table 59. Shire PLC Hemophilia Gene Therapy Product
Table 60. Shire PLC Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 61. Shire PLC Recent Development
Table 62. Sangamo Therapeutics Company Details
Table 63. Sangamo Therapeutics Business Overview
Table 64. Sangamo Therapeutics Hemophilia Gene Therapy Product
Table 65. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 66. Sangamo Therapeutics Recent Development
Table 67. Bioverativ Company Details
Table 68. Bioverativ Business Overview
Table 69. Bioverativ Hemophilia Gene Therapy Product
Table 70. Bioverativ Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 71. Bioverativ Recent Development
Table 72. BioMarin Company Details
Table 73. BioMarin Business Overview
Table 74. BioMarin Hemophilia Gene Therapy Product
Table 75. BioMarin Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 76. BioMarin Recent Development
Table 77. uniQure Company Details
Table 78. uniQure Business Overview
Table 79. uniQure Hemophilia Gene Therapy Product
Table 80. uniQure Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 81. uniQure Recent Development
Table 82. Freeline Therapeutics Company Details
Table 83. Freeline Therapeutics Business Overview
Table 84. Freeline Therapeutics Hemophilia Gene Therapy Product
Table 85. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2020-2025) & (US$ Million)
Table 86. Freeline Therapeutics Recent Development
Table 87. Hemophilia Gene Therapy Market Trends
Table 88. Hemophilia Gene Therapy Market Drivers
Table 89. Hemophilia Gene Therapy Market Challenges
Table 90. Hemophilia Gene Therapy Market Restraints
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia Gene Therapy Product Picture
Figure 2. Global Hemophilia Gene Therapy Market Share by Type: 2024 VS 2031
Figure 3. Hemophilia A Features
Figure 4. Hemophilia B Features
Figure 5. Global Hemophilia Gene Therapy Market Share by Application: 2024 VS 2031
Figure 6. Hemophilia A Gene Therapy
Figure 7. Hemophilia B Gene Therapy
Figure 8. Hemophilia Gene Therapy Report Years Considered
Figure 9. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 10. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Hemophilia Gene Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 12. North America Hemophilia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 13. Europe Hemophilia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. China Hemophilia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Japan Hemophilia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Southeast Asia Hemophilia Gene Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Hemophilia Gene Therapy Market Share by Players in 2024
Figure 18. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2024
Figure 20. North America Hemophilia Gene Therapy Market Share by Type (2020-2025)
Figure 21. North America Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 22. Europe Hemophilia Gene Therapy Market Share by Type (2020-2025)
Figure 23. Europe Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 24. China Hemophilia Gene Therapy Market Share by Type (2020-2025)
Figure 25. China Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 26. Japan Hemophilia Gene Therapy Market Share by Type (2020-2025)
Figure 27. Japan Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 28. Southeast Asia Hemophilia Gene Therapy Market Share by Type (2020-2025)
Figure 29. Southeast Asia Hemophilia Gene Therapy Market Share by Application (2020-2025)
Figure 30. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 31. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 32. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 33. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 34. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 35. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 36. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 37. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2020-2025)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
